Irritable bowel syndrome characterized by chronically recurring abdominal pain or discomfort and altered bowel habits,
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Abdominal pain at least 1 day per week for the past 3 months associated with two or more of the following: -Improvement with defecation -Onset associated with a change in frequency of stool
Exclusion criteria
Exclusion criteria: 1.Indication or contraindication to antiplatelet or anticoagulant therapy. 2.A clinically significant bleeding diathesis. 3. Positive pregnancy test, breast feeding 4. Risk of colon cancer include - Weight loss > 10% in the previous 3 months. - Positive of stool occult blood - Anemia -Hepatomegaly, gastric tumor, Lymphadenopathy, jaundice - Family history of colon cancer 5) Inconvenience to go to Thammasat hospital 6) ALT is higher than 3 times of upper limit of normal 7) eGFR is lower than 60 mL/min 8) Allergic to herbal drug
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain, Bloating and stool frequency of IBS IBS symtom will be recorded by the participant daily until Day 1 to Day 21 Pain score, Bloating score and stool frequency score | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life The begining of the study and Day 21 EQ5D5L of EuroQol Research Foundation ,Side effect of Thatbunjob 1 day and 7 days after stopping drug study Blood test for AST, ALT, creatinine, eGFR, CBC | — |
Countries
Thailand
Contacts
Faculty of Medicine, Thammasat university